Advertisement
Cardiff Oncology, Inc.

Cardiff Oncology, Inc. (CRDF) Stock Overview

Explore Cardiff Oncology, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CRDF●NASDAQ
HealthcareBiotechnology
$1.53
$0.02(1.32%)
U.S. Market is Open · 13:54
Advertisement

Cardiff Oncology, Inc. (CRDF)

Meyka AI Score

Z

Key Financials

Market Cap95.7M
P/E Ratio-2.08
EPS (TTM)$-0.67
ROE-0.95%
Fundamental Analysis

AI Price Forecasts

1 Month$0.85
3 Months$1.07
1 Year Target$2.73

CRDF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cardiff Oncology, Inc. (CRDF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.08 and a market capitalization of 95.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.28%
5-Day Change
-25.13%
1-Month Change
-18.13%
3-Month Change
-25.93%
6-Month Change
-34.27%
Year-to-Date (YTD) Change
-50.18%
1-Year Change
-60.11%
3-Year Change
-14.63%
5-Year Change
-81.65%
All-Time (Max) Change
-99.91%

Contact Information

https://www.cardiffoncology.com
858 952 7570
11055 Flintkote Avenue, San Diego, CA, 92121

Company Facts

32 Employees
IPO DateJul 27, 2004
CountryUS
Actively Trading

Frequently Asked Questions